APA (7th ed.) Citation

Saffari, A., Brösse, I., Tilburg, C. M. v., Hoffmann, G. F., Kölker, S., Witt, O., . . . Syrbe, S. (2019). Safety and efficacy of mTOR inhibitor treatment in patients with tuberous sclerosis complex under 2 years of age: A multicenter retrospective study. BioMed Central.

Chicago Style (17th ed.) Citation

Saffari, Afshin, Ines Brösse, Cornelis M. van Tilburg, Georg F. Hoffmann, Stefan Kölker, Olaf Witt, Till Milde, Andreas Ziegler, and Steffen Syrbe. Safety and Efficacy of MTOR Inhibitor Treatment in Patients with Tuberous Sclerosis Complex Under 2 years of Age: A Multicenter Retrospective Study. London: BioMed Central, 2019.

MLA (9th ed.) Citation

Saffari, Afshin, et al. Safety and Efficacy of MTOR Inhibitor Treatment in Patients with Tuberous Sclerosis Complex Under 2 years of Age: A Multicenter Retrospective Study. BioMed Central, 2019.